Salta al contenuto principale
Corporate navigation
Gruppo
Sostenibilità
Investitori
Careers
Newsroom
Internazionale
US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
IT
EN
Mobile: Main menu
BACK
Immunodiagnostics
Immunodiagnostics
BACK
Overview
Infectious diseases
Gastrointestinal diseases
Hepatitis and retroviruses
Endocrinology
Metabolic disorders
Tumor Markers
Instruments
BACK
Instruments
LIAISON
®
XL
LIAISON
®
XS
Dialog
Molecular Diagnostics
Molecular Diagnostics
BACK
Overview
Technologies
BACK
Technologies
VERIGENE
®
NanoGrid Technology
Simplexa™ Real-Time PCR
xTAG
®
and NxTAG
®
Technology
Instruments
BACK
Instruments
LIAISON
®
MDX
The VERIGENE
®
System
MAGPIX
®
System
Kits and Reagents
BACK
Kits and Reagents
By Disease State
BACK
By Disease State
Bloodstream
CNS
Gastrointestinal
Genetics
Healthcare-Associated Infections
Respiratory
Women’s Health
By Format
BACK
By Format
Molecular Primer Pairs
Molecular Controls
Molecular Reagents
Dialog
Product Documentation
Luminex LTG
Luminex LTG
BACK
Overview
xMAP
®
Technology
BACK
xMAP
®
Technology
Applications
BACK
Applications
Bead-Based Multiplexing
xMAP
®
Assay Automation
Immunogenicity
xMAP
®
Microspheres
Instruments
BACK
Instruments
xMAP INTELLIFLEX
®
System
FLEXMAP 3D
®
System
Luminex
®
200™ System
MAGPIX
®
System
Reagents & Accessories
BACK
Reagents & Accessories
xMAP
®
Kit Finder
Microspheres
BACK
Microspheres
MagPlex-TAG™ Microspheres
MagPlex
®
Microspheres
MagPlex
®
-Avidin Microspheres
MagPlex
®
Monitoring Microspheres
MicroPlex
®
Microspheres
SeroMAP
TM
Microspheres
Coupling Accessories
BACK
Coupling Accessories
xMAP
®
Antibody Coupling Kit
Magnetic separators
xPONENT
®
Software
Product documentation
Service & Support
Service & Support
BACK
Overview
Immunodiagnostics
Molecular Diagnostics
Luminex LTG
BACK
Luminex LTG
Field Service Training Sessions
Maintenance Support Plans
Luminex Learning Sessions
LuminexPLORE Lab
My Luminex
Mobile: Corporate navigation
Gruppo
Sostenibilità
Investitori
Careers
Newsroom
Mobile: Company
BACK
Gruppo
Chi siamo
BACK
Chi siamo
La nostra storia
Sostenibili per natura
Leadership
BACK
Leadership
Michele Denegri
Carlo Rosa
Chen Even
Angelo Rago
Piergiorgio Pedron
Stefano Ronchi
Modello di business
Specialisti nell’innovazione
Governance
BACK
Governance
Documenti sulla Governance
BACK
Documenti sulla Governance
Statuto
Procedure
Codice Etico e Modello 231
Relazioni sul Governo Societario e gli assetti proprietari
Organi sociali
Assemblea degli Azionisti
Remunerazione
BACK
Remuneration
Relazioni sulla Remunerazione
Documenti informativi Piani di Incentivazione
Operazioni di Internal dealing
Operazioni su azioni proprie
Assetti Proprietari
BACK
Struttura della proprietà
Capitale Sociale
Voto Maggiorato
Calendario Finanziario
Obblighi di trasparenza
Protezione dei Dati Personali
Diasorin nel mondo
Mobile: Sustainability
BACK
Sostenibilità
Temi di materialità
BACK
Temi di materialità
Salute e sicurezza
Gestione dei rapporti con le comunità locali
Formazione e sviluppo del personale
Occupazione e dialogo con le parti sociali
Benessere del personale
Diversità e inclusione
Gestione ambientale
Etica di business, lotta alla corruzione e al comportamento anticompetitivo
Ricerca, innovazione ed eccellenza tecnologica
Customer satisfaction
Qualità del prodotto e del processo
Diritti Umani
ESG
Obiettivi ESG 2023-2025
Risorse
Mobile: Investors
BACK
Investitori
Investor Day 2023
Financial corner
BACK
Financial corner
Risultati
Comunicati stampa
Presentazioni
Bilanci e Relazioni
Bond
Coverage
Keep in touch
Calendario
Stock price
Indici di Borsa e codici trading
Documenti informativi
Mobile: Careers
BACK
Careers
Principi del merito
BACK
Principi del merito
La nostra cultura
Diversità e inclusione
People Strategy
Unisciti a noi
Unisciti a noi
Mobile: Newsroom
BACK
Newsroom
Comunicati stampa
Press Kit
Galleria video
Galleria immagini
Internazionale
US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
IT
EN
Main menu
BACK
Immunodiagnostics
Immunodiagnostics
BACK
Overview
Infectious diseases
Gastrointestinal diseases
Hepatitis and retroviruses
Endocrinology
Metabolic disorders
Tumor Markers
Instruments
BACK
Instruments
LIAISON
®
XL
LIAISON
®
XS
Dialog
Molecular Diagnostics
Molecular Diagnostics
BACK
Overview
Technologies
BACK
Technologies
VERIGENE
®
NanoGrid Technology
Simplexa™ Real-Time PCR
xTAG
®
and NxTAG
®
Technology
Instruments
BACK
Instruments
LIAISON
®
MDX
The VERIGENE
®
System
MAGPIX
®
System
Kits and Reagents
BACK
Kits and Reagents
By Disease State
BACK
By Disease State
Bloodstream
CNS
Gastrointestinal
Genetics
Healthcare-Associated Infections
Respiratory
Women’s Health
By Format
BACK
By Format
Molecular Primer Pairs
Molecular Controls
Molecular Reagents
Dialog
Product Documentation
Luminex LTG
Luminex LTG
BACK
Overview
xMAP
®
Technology
BACK
xMAP
®
Technology
Applications
BACK
Applications
Bead-Based Multiplexing
xMAP
®
Assay Automation
Immunogenicity
xMAP
®
Microspheres
Instruments
BACK
Instruments
xMAP INTELLIFLEX
®
System
FLEXMAP 3D
®
System
Luminex
®
200™ System
MAGPIX
®
System
Reagents & Accessories
BACK
Reagents & Accessories
xMAP
®
Kit Finder
Microspheres
BACK
Microspheres
MagPlex-TAG™ Microspheres
MagPlex
®
Microspheres
MagPlex
®
-Avidin Microspheres
MagPlex
®
Monitoring Microspheres
MicroPlex
®
Microspheres
SeroMAP
TM
Microspheres
Coupling Accessories
BACK
Coupling Accessories
xMAP
®
Antibody Coupling Kit
Magnetic separators
xPONENT
®
Software
Product documentation
Service & Support
Service & Support
BACK
Overview
Immunodiagnostics
Molecular Diagnostics
Luminex LTG
BACK
Luminex LTG
Field Service Training Sessions
Maintenance Support Plans
Luminex Learning Sessions
LuminexPLORE Lab
My Luminex
Home
Gruppo
Governance
Operazioni su azioni proprie
Operazioni su azioni proprie
Seleziona anno
2024
2023
2022
2021
2020
2018
(-)
2016
04/07/2016
Allegato 3F (Buy back) - Giugno 2016
3.93 KB
Scarica
10/06/2016
Conclusione programma acquisto azioni proprie
327.14 KB
Scarica
01/06/2016
Allegato 3F (Buy back) - Maggio 2016
4.59 KB
Scarica
12/05/2016
Avvio programma acquisto azioni proprie
216.07 KB
Scarica